BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2754616)

  • 1. [The synthesis of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride (cetraxate hydrochloride) by means of enzymatic debenzylation].
    Kuroda H; Miyadera A; Kaneuchi T; Imura A
    Yakugaku Zasshi; 1989 Mar; 109(3):157-62. PubMed ID: 2754616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification, and some properties and reactivities of cetraxate benzyl ester hydrochloride-hydrolyzing enzyme.
    Kuroda H; Miyadera A; Imura A; Suzuki A
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):2929-32. PubMed ID: 2632040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of cetraxate [4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride], a new anti-ulcer agent.
    Suzuki Y; Ito M; Sudo Y
    Jpn J Pharmacol; 1979 Dec; 29(6):829-38. PubMed ID: 161596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid derivatives with enhanced absorption.
    Svahn CM; Merenyi F; Karlson L; Widlund L; Grälls M
    J Med Chem; 1986 Apr; 29(4):448-53. PubMed ID: 3959024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic and pharmacological studies on cetraxate, an anti-ulcer agent].
    Tanaka H; Naito S
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):357-66. PubMed ID: 4029808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and inhibitory effects on gastric lesions of trans-guanidinomethylcyclohexane carboxylic acid arylamides.
    Ueda H; Momoi Y; Ikeda T; Kakegawa H; Miyataka H; Matsumoto H; Satoh T
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):522-4. PubMed ID: 8477502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of p-hydroxyphenyl-propionic ester of tranexamic acid hydrochloride (Cetraxate) on peptic ulcer. Multi-center clinical study.
    Ishimori A; Yamagata S; Taima T
    Arzneimittelforschung; 1979; 29(10):1625-32. PubMed ID: 391240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ulcer agent, cetraxate hydrochloride (Neuer), prevents subcellular redistribution of lysosomal enzyme in caerulein-induced pancreatitis in the rat.
    Hirano T; Takeuchi S
    J Int Med Res; 1994; 22(2):107-12. PubMed ID: 8020637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-ulcer effects of 4'-(2-carboxyetyl) phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats.
    Suzuki Y; Hayashi M; Ito M; Yamagami I
    Jpn J Pharmacol; 1976 Aug; 26(4):471-80. PubMed ID: 1003703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.
    Tatsuta M; Yamamura H; Iishi H; Taniguchi H
    Arzneimittelforschung; 1987 Sep; 37(9):1045-8. PubMed ID: 3435599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cetraxate in duodenal ulcer, a double-blind clinical study (author's transl)].
    Yu JY; Wang TH; Wang CY; Chen RR; Sung JL
    Taiwan Yi Xue Hui Za Zhi; 1981 Apr; 80(4):442-8. PubMed ID: 7031178
    [No Abstract]   [Full Text] [Related]  

  • 13. Cetraxate is not superior to placebo in the treatment of duodenal ulcer.
    Bianchi Porro G; Ardizzone S; Petrillo M
    J Clin Gastroenterol; 1990 Apr; 12(2):234-6. PubMed ID: 2182708
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic preparation of D-beta-acetylthioisobutyric acid and cetraxate hydrochloride using a stereo- and/or regioselective hydrolase, 3,4-dihydrocoumarin hydrolase from Acinetobacter calcoaceticus.
    Honda K; Kataoka M; Shimizu S
    Appl Microbiol Biotechnol; 2002 Nov; 60(3):288-92. PubMed ID: 12436309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cetraxate and antacid in the treatment of gastric ulcer. A controlled clinical trial.
    Wilairatana S; Kladchareon N; Kositsurunkakul S; Israsena S
    J Med Assoc Thai; 1985 Jul; 68(7):333-41. PubMed ID: 3903020
    [No Abstract]   [Full Text] [Related]  

  • 16. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma.
    Katagiri F; Sato Y; Itoh H; Takeyama M
    J Pharm Pharmacol; 2004 Apr; 56(4):557-61. PubMed ID: 15099451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of cetraxate against acute gastritis and acute aggravation of chronic gastritis. Endoscopic investigation by the double-blind method.
    Yamagata S; Miura K
    Arzneimittelforschung; 1983; 33(8):1191-5. PubMed ID: 6357203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cimetidine and cetraxate on the biosynthetic activity of mucus glycoproteins in organ culture of rat gastric mucosa (author's transl)].
    Ishihara K; Ohara S; Azuumi Y; Hotta K; Kakei M; Okabe H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Oct; 78(10):1896-900. PubMed ID: 7328821
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicinal chemical studies on antiplasmin drugs. VIII. 4-Aminomethylcyclohexanecarboxylic acid derivatives having a carboxyl or carboxymethyl group at C2.
    Isoda S; Yamaguchi H
    Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2337-46. PubMed ID: 7428125
    [No Abstract]   [Full Text] [Related]  

  • 20. Biocatalytic deprotection of a cetraxate ester by Microbacterium sp. strain 7-1W cells.
    Honda K; Sakamoto K; Kita S; Kataoka M; Shimizu S
    Biosci Biotechnol Biochem; 2003 Jan; 67(1):192-4. PubMed ID: 12619695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.